ADC Therapeutics SA (ADCT) Earnings Date & Reports

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ADCT is expected to report earnings to rise 61.32% to -40 cents per share on May 12

ADC Therapeutics SA ADCT Stock Earnings Reports

Q1'25

Est.

$-0.40

Q4'24

Beat

by $0.18

Q3'24

Beat

by $0.10

Q2'24

Beat

by $0.08

Q1'24

Beat

by $0.17

The last earnings report on March 27 showed earnings per share of -25 cents, beating the estimate of -43 cents. With 348.17K shares outstanding, the current market capitalization sits at 131.78M.

View a ticker or compare two or three

Compare

ADCT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ADCT
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Route de la Corniche 3B

Phone

+41 216530200

Employees

274

Web

https://www.adctherapeutics.com